Member

Adam JARUBAS

EPP · Poland

Group: EPP PPE
Country: Poland
Roll-call participation: 57.6 %ⓘ of 66 roll calls in office · chamber median 93.9 % · 2024 (from july), final votes
With majority line: 38 of 38ⓘ EPP median 95.3 %

More facts (5)

National party: PSL Polskie Stronnictwo Ludowe
In office: Since 16 Jul 2024
Against clear line: 0 of 38 votesⓘ
Committees: ENVI (substitute), ITRE, SANT (chair)
Member id: 197517

National party: PSL Polskie Stronnictwo Ludowe
In office: Since 16 Jul 2024
Against clear line: 0 of 38 votesⓘ
Committees: ENVI (substitute), ITRE, SANT (chair)
Member id: 197517

Cite this page

EP profile

Link to this page

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Period Whole term 2024 (from July)2025 2026

Custom dates

Votes Final votes66 All roll calls516

Roll-call participation ⓘ

57.6 %

38 of 66 final votes while in office

EPP median: 92.4 % (−34.8 pts)

Chamber median: 93.9 %

With majority line ⓘ

38 of 38

votes where their group had a line — too few for a rate

EPP median: 95.3 %

Against clear line ⓘ

0 of 38

votes where their group had a clear line — too few for a rate

Abstention ⓘ

0 of 38

votes cast — too few for a rate

Participation 57.6 % — EPP median 92.4 %, 184 members.ⓘ

Data as a table

Participation among the 184 members of the EPP with enough votes.
Figure	Participation
Adam JARUBAS	57.6 %
EPP median	92.4 %
Lowest in the group	37.9 %
Highest in the group	100.0 %
Members	184

2024 (from July), 66 final votes; 66 of 81 decisions had a final vote recorded by name. The dots are the other members of EPP; no ranks.
“No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Show Final votes All roll calls

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
Date	Decision	Result	Position	Majority line
17 Sept 2026	Deteriorating situation of media freedom and freedom of expression in Hong Kong following the recent arrest of bookseller Leticia Wong and the convictions of Lee Cheuk-yan and Chow Hang-tung	Adopted 459 for, 12 against, 86 abstained	Position: For	Majority line: For
17 Sept 2026	Political prisoners in Cuba, in particular the case of Félix Navarro and his daughter Saylí Navarro	Adopted 374 for, 198 against, 19 abstained	Position: For	Majority line: For
17 Sept 2026	An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector	Adopted 514 for, 61 against, 33 abstained	Position: For	Majority line: For
17 Sept 2026	Post-electoral repression in Zambia and the killing of Mutotwe Kafwaya	Adopted 562 for, 1 against, 33 abstained	Position: For	Majority line: For
17 Sept 2026	Impact of social media and the online environment on young people	Adopted 395 for, 136 against, 80 abstained	Position: For	Majority line: For
17 Sept 2026	The role of social, economic and environmental standards in safeguarding fair competition for all aquatic food products and improving food security	Adopted 467 for, 92 against, 44 abstained	Position: For	Majority line: For
17 Sept 2026	Evaluation of the Common Fisheries Policy and follow-up	Adopted 368 for, 172 against, 69 abstained	Position: For	Majority line: For
17 Sept 2026	Narco-trafficking in Europe’s waters: protecting our borders and supporting our law enforcement officers	Adopted 601 for, 4 against, 5 abstained	Position: For	Majority line: For
17 Sept 2026	The recent hybrid attacks and instrumentalisation of migrants in Ceuta and the need for a coordinated response to protect EU’s external borders	Adopted 339 for, 225 against, 16 abstained	Position: For	Majority line: For
17 Sept 2026	Strengthening global health resilience in partner countries	Adopted 319 for, 142 against, 19 abstained	Position: For	Majority line: For
16 Sept 2026	Simplification of intra-EU transfers of defence-related products and simplification of security and defence procurement (Omnibus V)	Passed 549 for, 92 against, 27 abstained	Position: For	Majority line: For
16 Sept 2026	Acceleration of permit-granting for defence readiness projects (Omnibus V)	Passed 540 for, 105 against, 22 abstained	Position: For	Majority line: For
16 Sept 2026	Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V)	Passed 530 for, 125 against, 12 abstained	Position: For	Majority line: For
16 Sept 2026	Establishing the Single Market and Customs Programme for the period 2028-2034	Passed 496 for, 53 against, 125 abstained	Position: For	Majority line: For
16 Sept 2026	Instrument for Nuclear Safety Cooperation 2028-2034	Passed 600 for, 21 against, 48 abstained	Position: For	Majority line: For
16 Sept 2026	Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034	Passed 625 for, 20 against, 22 abstained	Position: For	Majority line: For
16 Sept 2026	EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime	Consent given 549 for, 75 against, 30 abstained	Position: For	Majority line: For
16 Sept 2026	EU-UK Agreement regarding cooperation on the application of their respective competition laws	Consent given 640 for, 5 against, 26 abstained	Position: For	Majority line: For
16 Sept 2026	EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme	Consent given 631 for, 7 against, 15 abstained	Position: For	Majority line: For
16 Sept 2026	EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme	Consent given 612 for, 8 against, 16 abstained	Position: For	Majority line: For
16 Sept 2026	Genetically modified soybean GMB151 x DAS-44406-6	Objection passed 442 for, 184 against, 12 abstained	Position: Against	Majority line: Against
16 Sept 2026	Genetically modified soybean MON 94313	Objection passed 457 for, 184 against, 10 abstained	Position: Against	Majority line: Against
16 Sept 2026	Genetically modified maize MON 87460	Objection passed 433 for, 159 against, 10 abstained	Position: Against	Majority line: Against
16 Sept 2026	Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure	Adopted 470 for, 129 against, 62 abstained	Position: For	Majority line: For
16 Sept 2026	An EU cardiovascular diseases strategy	Adopted 545 for, 47 against, 75 abstained	Position: For	Majority line: For
16 Sept 2026	Gender inequalities in health, specifically as regards gender-specific conditions	Adopted 390 for, 218 against, 29 abstained	Position: Against	Majority line: Against
15 Sept 2026	Carbon Border Adjustment Mechanism: extension of its scope to downstream goods and anti-circumvention measures	Passed 464 for, 50 against, 159 abstained	Position: For	Majority line: For
15 Sept 2026	Establishing the Temporary Decarbonisation Fund	Passed 433 for, 97 against, 146 abstained	Position: Abstained ≠ group	Majority line: For
15 Sept 2026	Market stability reserve for the EU Emissions Trading System (EU ETS): ceasing the invalidation of allowances	Passed 367 for, 240 against, 59 abstained	Position: For	Majority line: For
15 Sept 2026	Market stability reserve for the buildings, road transport and additional sectors	Passed 467 for, 158 against, 41 abstained	Position: No vote recorded	Majority line: For
15 Sept 2026	Implementation into Union law of measures adopted by regional fisheries management organisations	Passed 559 for, 48 against, 62 abstained	Position: No vote recorded	Majority line: For
15 Sept 2026	General Fisheries Commission for the Mediterranean (GFCM): fishing in the GFCM Agreement area	Passed 580 for, 51 against, 39 abstained	Position: For	Majority line: For
15 Sept 2026	Temporary trade-liberalisation measures applicable to Armenian products	Passed 583 for, 49 against, 39 abstained	Position: For	Majority line: For
15 Sept 2026	Draft amending budget No 2/2026: update of revenue (own resources) and adjustments to expenditure	Passed 440 for, 127 against, 104 abstained	Position: For	Majority line: For
15 Sept 2026	Findings and recommendations of the Special Committee on the European Democracy Shield	Adopted 420 for, 220 against, 26 abstained	Position: For	Majority line: For
15 Sept 2026	Implementation of the Council Recommendation on a Bridge to Jobs – Reinforcing the Youth Guarantee	Adopted 530 for, 77 against, 61 abstained	Position: For	Majority line: For
15 Sept 2026	The EU Youth Strategy 2019–2027	Adopted 477 for, 124 against, 66 abstained	Position: For	Majority line: For
15 Sept 2026	Global role of the euro	Adopted 405 for, 146 against, 60 abstained	Position: For	Majority line: For
9 Jul 2026	Establishment of the digital euro	Negotiating mandate approved 416 for, 169 against, 22 abstained	Position: No vote recorded	Majority line: For
9 Jul 2026	The threat of war crimes, the escalating violations of international humanitarian law and the human rights situation in El-Obeid, Sudan	Adopted 476 for, 28 against, 96 abstained	Position: No vote recorded	Majority line: For
9 Jul 2026	Ongoing persecution of Christians in Nigeria, notably the Kawel village massacre	Adopted 510 for, 1 against, 86 abstained	Position: No vote recorded	Majority line: For
9 Jul 2026	Feasibility of a 28th tax regime and its potential to support EU competitiveness	Adopted 366 for, 192 against, 39 abstained	Position: No vote recorded	Majority line: For
8 Jul 2026	EU–Mexico Political, Economic and Cooperation Strategic Partnership Agreement	Consent given 479 for, 119 against, 65 abstained	Position: For	Majority line: For
8 Jul 2026	Protection of the environment through criminal law	Consent given 499 for, 99 against, 69 abstained	Position: For	Majority line: For
8 Jul 2026	EU–Mexico Interim Agreement on Trade	Consent given 474 for, 131 against, 60 abstained	Position: For	Majority line: For
8 Jul 2026	EU–Morocco Euro-Mediterranean Aviation Agreement: accession to the EU of Croatia (Protocol)	Consent given 625 for, 16 against, 20 abstained	Position: For	Majority line: For
8 Jul 2026	EU-Morocco Agreement for scientific and technological cooperation setting out the terms and conditions for the participation of Morocco in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA): amendment and supplement	Consent given 573 for, 35 against, 37 abstained	Position: For	Majority line: For
8 Jul 2026	Trajectory to decrease the contribution of high indirect land-use change-risk biofuels, bioliquids and biomass fuels to renewable energy targets	Objection passed 388 for, 248 against, 24 abstained	Position: For	Majority line: For
8 Jul 2026	Lead in certain fishing tackle	Objection failed 197 for, 455 against, 7 abstained	Position: Against	Majority line: Against
8 Jul 2026	Genetically modified maize NK603 × T25	Objection passed 460 for, 189 against, 14 abstained	Position: Against	Majority line: Against

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 6 of 16 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Roll calls held at each sitting while in office and how many of them the member voted in.
Sitting	Roll calls	Voted in
17 Jul 2024	1	1
18 Sept 2024	2	0
19 Sept 2024	6	0
8 Oct 2024	1	0
9 Oct 2024	2	2
10 Oct 2024	1	1
22 Oct 2024	5	5
23 Oct 2024	2	2
24 Oct 2024	2	2
14 Nov 2024	5	5
26 Nov 2024	8	0
27 Nov 2024	7	7
28 Nov 2024	6	0
17 Dec 2024	6	6
18 Dec 2024	7	7
19 Dec 2024	5	0

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
Select	Member	Group	Country	Agreement	Baseline
Select Krzysztof HETMAN	Krzysztof HETMAN	EPP	Poland	96 % of 4 016 shared	89 %
Select Jacek PROTAS	Jacek PROTAS	EPP	Poland	95 % of 4 257 shared	89 %
Select Marta WCISŁO	Marta WCISŁO	EPP	Poland	95 % of 4 353 shared	89 %
Select Bogdan Andrzej ZDROJEWSKI	Bogdan Andrzej ZDROJEWSKI	EPP	Poland	95 % of 4 363 shared	89 %
Select Andrzej BUŁA	Andrzej BUŁA	EPP	Poland	95 % of 4 003 shared	89 %
Select Kamila GASIUK-PIHOWICZ	Kamila GASIUK-PIHOWICZ	EPP	Poland	94 % of 4 317 shared	89 %
Select Dariusz JOŃSKI	Dariusz JOŃSKI	EPP	Poland	94 % of 4 334 shared	89 %
Select Bartosz ARŁUKOWICZ	Bartosz ARŁUKOWICZ	EPP	Poland	94 % of 4 178 shared	89 %
Select Andrzej HALICKI	Andrzej HALICKI	EPP	Poland	94 % of 4 105 shared	89 %
Select Bartłomiej SIENKIEWICZ	Bartłomiej SIENKIEWICZ	EPP	Poland	94 % of 4 317 shared	89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
Select	Member	Group	Country	Agreement	Baseline
Select Eugen TOMAC	Eugen TOMAC	Renew	Romania	81 % of 3 166 shared	82 %
Select Katri KULMUNI	Katri KULMUNI	Renew	Finland	81 % of 3 539 shared	82 %
Select Urmas PAET	Urmas PAET	Renew	Estonia	81 % of 3 836 shared	82 %
Select Dan BARNA	Dan BARNA	Renew	Romania	80 % of 3 840 shared	82 %
Select Hilde VAUTMANS	Hilde VAUTMANS	Renew	Belgium	80 % of 4 231 shared	82 %
Select Marie-Pierre VEDRENNE	Marie-Pierre VEDRENNE Former member	Renew	France	80 % of 1 976 shared	82 %
Select Bart GROOTHUIS	Bart GROOTHUIS	Renew	Netherlands	79 % of 3 307 shared	82 %
Select Jeannette BALJEU	Jeannette BALJEU	Renew	Netherlands	79 % of 3 942 shared	82 %
Select Ivars IJABS	Ivars IJABS	Renew	Latvia	79 % of 3 424 shared	82 %
Select Benoit CASSART	Benoit CASSART	Renew	Belgium	79 % of 4 014 shared	82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
Body	Role	From	To
Committee on the Environment, Climate and Food SafetyENVI Committee	Substitute	20 Jan 2025	now
Committee on Industry, Research and EnergyITRE Committee	Member	19 Jul 2024	now
Committee on Public HealthSANT Committee	Chair	29 Jan 2025	now
Delegation for relations with the People's Republic of ChinaD-CN Delegation	Member	19 Sept 2024	now
Delegation for relations with the Korean PeninsulaDKOR Delegation	Substitute	19 Sept 2024	now
Intergroup on Anti-CorruptionIG10-01 Intergroup / working group	Member	16 Jan 2025	now
Committee on the Environment, Public Health and Food SafetyENVI Committee	Substitute	19 Jul 2024	19 Jan 2025
Committee on Public HealthSANT Committee	Member	23 Jan 2025	28 Jan 2025
Subcommittee on Public HealthSANT Subcommittee	Chair	23 Jul 2024	19 Jan 2025
Subcommittee on Public HealthSANT Subcommittee	Member	19 Jul 2024	22 Jul 2024

Show all 10 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
Dossier	Role	Committee	Date
EU Emissions Trading System: heat and fuel benchmark values for 2026–2030	Rapporteur	ENVI	2 Sept 2026
Amending Directives 2001/18/EC and 2010/53/EU as regards the placing on the market of genetically modified micro-organisms and the processing of organs	Rapporteur	SANT	16 Apr 2026
24th EU-Republic of South Korea Interparliamentary Meeting\nSeoul 27-29 May 2026	Official delegation	DKOR	16 Apr 2026
Amending Regulation (EU) 2023/956 as regards the extension of its scope to downstream goods and anti-circumvention measures	Shadow rapporteur	ENVI	16 Apr 2026
No dossier named	Official delegation	SANT	24 Mar 2026
Amending Regulation (EU) 2023/956 as regards the extension of its scope to downstream goods and anti-circumvention measures	Shadow rapporteur	ENVI	24 Mar 2026
Laying down the multiannual financial framework for the years 2028 to 2034	Opinion rapporteur	SANT	11 Feb 2026
Guidelines for the 2027 Budget - Section III	Opinion rapporteur	SANT	11 Feb 2026
No dossier named	Official delegation	SANT	28 Jan 2026
No dossier named	Official delegation	SANT	9 Oct 2025

Show all 14 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

14 contributions recorded; 2 on behalf of their group; 23 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
Date	Debate	Kind	Verbatim
14 Sept 2026	Emissions trading (joint debate)	Speech · 1 min	Read
9 Feb 2026	World Cancer Day (debate)	Speech · 1 min	Read
19 Jan 2026	Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest (debate)	Speech · 2 min	Read
16 Dec 2025	Presentation of the EU Cardiovascular Health Plan (debate)	Speech · 2 min	Read
11 Sept 2025	Solidarity with Poland following the deliberate violation of Polish airspace by Russian drones (debate)	Speech · 1 min	Read
21 May 2025	Amending Regulation (EU) 2023/956 as regards simplifying and strengthening the carbon border adjustment mechanism (debate) on behalf of EPP	Speech · 2 min	Read
3 Apr 2025	European Action Plan on Rare Diseases (debate)	Speech · 2 min	Read
2 Apr 2025	European Steel and Metals Action Plan (debate)	Speech · 2 min	Read
11 Mar 2025	Presentation of the proposal on Critical Medicines Act (CMA) (debate)	Speech · 2 min	Read
12 Feb 2025	Silent crisis: the mental health of Europe’s youth (debate)	Speech · 2 min	Read

Show all 14 recent contributions

Questions and motions, 29

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
Date	Title	Kind	Answer
22 Jun 2026	SCoPAFF’s reclassification of plant protection products E-10-2026-002564	Written questionwith 1 co-author	Not yet answered
17 Jun 2026	Recognition of obesity as a chronic disease under EU public health policy E-10-2026-002516	Written questionwith 17 co-authors	24 Aug 2026
25 Mar 2026	Ensuring competition and strategic autonomy in the AI gigafactory supply chain E-10-2026-001255	Written questionwith 17 co-authors	19 Jun 2026
24 Feb 2026	Ensuring risk assessment as the basis for proportionate regulation of cosmetic products E-10-2026-000762	Written questionwith 20 co-authors	16 Apr 2026
18 Feb 2026	Inspections to ensure regulatory conformity of cosmetic products in the single market with the Cosmetic Products Regulation E-10-2026-000687	Written questionwith 22 co-authors	Not yet answered
18 Feb 2026	Checks on the presence of prohibited substances and trace impurities in non-EU cosmetic products entering the single market E-10-2026-000688	Written questionwith 21 co-authors	21 May 2026
13 Feb 2026	Commission proceedings concerning complaint CPLT(2023)02625 on Poland’s restrictions on pharmacy ownership E-10-2026-000645	Written questionwith 2 co-authors	26 Mar 2026
11 Feb 2026	Protecting allergic consumers by harmonising EU ingredient labelling E-10-2026-000591	Written questionwith 5 co-authors	17 Apr 2026
9 Feb 2026	MOTION FOR A RESOLUTION on World Cancer Day B-10-2026-0141	Motion for a resolutionwith 18 co-authors	—
3 Feb 2026	Ensuring patient safety for all Europeans: the need to establish a warning system for disqualified medical professionals E-10-2026-000428	Written questionwith 24 co-authors	27 Mar 2026

Show all 29 questions and motions

Amendments tabled in committee, 114

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
Date	Text amended	Committee	Amendments
11 Sept 2026	Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154	SANT	21
11 Sept 2026	Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014	SANT	35
28 Jul 2026	Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890	SANT	3
28 Jul 2026	Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887	SANT	5
28 Jul 2026	Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891	SANT	8
27 Jul 2026	Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-791073	CJ72	2
27 Jul 2026	Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-791874	CJ72	2
27 Jul 2026	Amending Regulations (EU) 2016/679, (EU) 2018/1724, (EU) 2018/1725, (EU) 2023/2854 and Directives 2002/58/EC, (EU) 2022/2555 and (EU) 2022/2557 as regards the simplification of the digital legislative framework, and repealing Regulations (EU) 2018/1807, (EU) 2019/1150, (EU) 2022/868, and Directive (EU) 2019/1024 (Digital Omnibus) CJ72-AM-791873	CJ72	19
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932	CJ53	7
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938	CJ53	8

Show all 114 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

Group European People’s Party EPP · Centre-right · Christian democracy, conservatism

National delegation

Delegation Poland National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink: https://news.eu-parl.st-solutions.dev/members/197517?period=2024&scope=final&vscope=final
Official source: Member’s profile, European Parliament
Data source: EP Open Data: member record
Licensed CC BY 4.0.
Data version: data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved: 25 September 2026

Cite as

EU Parl Watch Research (2026). “Adam JARUBAS”. Member record. memberId 197517. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/197517?period=2024&scope=final&vscope=final (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/197517. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/197517?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.

BibTeX

@misc{epw-member-197517,
  author = {{EU Parl Watch Research}},
  title = {{Adam JARUBAS}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/197517?period=2024&scope=final&vscope=final}},
  url = {https://news.eu-parl.st-solutions.dev/members/197517?period=2024&scope=final&vscope=final},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 197517. Official source: https://www.europarl.europa.eu/meps/en/197517. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}